Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-11-06
2007-11-06
Chen, Shin-Lin (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093210, C435S320100, C435S455000, C536S023500, C536S024100
Reexamination Certificate
active
11048543
ABSTRACT:
This invention provides a method for reversing the cancerous phenotype of a cancer cell by introducing a nucleic acid having the melanoma differentiation associated gene (mda-7) into the cell under conditions that permit the expression of the gene so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a method for reversing the cancerous phenotype of a cancer cell by introducing the gene product of the above-described gene into the cancerous cell so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a pharmaceutical composition having the melanoma differentiation associated gene (mda-7) or the gene product of the melanoma differentiation associated gene (mda-7) effective to reverse the cancerous phenotype of a cancer cell and a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5480968 (1996-01-01), Kraus et al.
patent: 5643761 (1997-07-01), Fisher et al.
patent: 5710137 (1998-01-01), Fisher
patent: 6190909 (2001-02-01), Levinson et al.
patent: 6355622 (2002-03-01), Fisher
patent: 6720408 (2004-04-01), Fisher et al.
patent: WO95/11986 (1995-05-01), None
patent: WO98/06441 (1998-02-01), None
patent: WO00/55310 (2000-09-01), None
patent: WO01/05437 (2001-01-01), None
Rudinger, 1976, Peptide Hormones, Edited by Parsons, University Park Press, Baltimore, p. 1-7.
Kaye et al., 1990, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6922-6926.
Skolnick et al., 2000, Trends in Biotech, vol. 18, p. 34-39.
Deonarain, 1998, Expert Opin. Ther. Pat., vol. 8, pp. 53-69.
Verma, Sep. 1997, Nature, vol. 389, pp. 239-242.
Eck et al., 1996, Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, p. 77-101.
Gorecki, 2001, Expert Opin. Emerging Drugs, 6(2): 187-198.
Cunningham et al. Mol. Ther. (2005), 149-159. Clinical and Logical Effects of an Intratumoral Injection of mda-7 (IL24; INGN 241) in Patients with Advanced Carcinoma: A Phase I Study.
Lebedeva et al. Mol. Ther. (2005), 4-18. mda-7/IL 24: Exploiting Cancer's Achilles' Heel.
Tong et al. Molecular Therapy (2005), 160-172. Intratumoral Injection of INGN 241, A Nonreplicating Adenovector Expressing the Melanoma-Dofferentation Associated Gene-7 (mda-7/IL24): Niologic Outcome in Advanced Cancer Patients.
Introgen Therapeutics, Inc. Press release Jun. 7, 2004. Introgen Presents Final Data From INGN 241 Phase I Study, Demonstrating Clinical and Biologic Activity.
Chen, J. et al. Mol Ther. (2003), 8:220-229. Tumor suppressor MDA-7/IL-24 selectively inhibits vascular smooth muscle cell growth and migration.
Fisher et al., Cancer Biol. and Ther. (2003), 2:Suppl. 1, S23-37. 2003. Mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: From the laboratory to the clinic.
Introgen Therapeutics, Inc., Press release, Sep. 25, 2003. Publication shows Introgen's INGN 241 drug overcomes common cancer toxicity pathways.
Prochazkova et al., (2003). Comparative study of apoptosis-detecting techniques: TUNEL, apostain, and lamin B. Biotechniques 35(3):528-534.
Sauane, M. et al.. J Cell Physiol. (2003), 196:334-345. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways.
Waxman et al., (2003). Harnessing apoptosis for improved anticancer gene therapy. Cancer Research 63:8563-8572.
Cao, X. X. et al.. Mol Med. (2002), 8:869-876. Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL.
Kawabeet al. (2002). Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol Ther. 6(5):637-644.
Saeki et al., (2002). Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 21(29):4558-4566.
Smyth et al., (2002). Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system. Biotechniques 32(3):648-665.
Mhashilkar A. M. et al. Mol Med. (2001), 7:271-282. Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy.
Saeki et al., (2000). Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther. 7(23):2051-2057.
Green (1998). Apoptotic pathways: the roads to ruin. Cell 94:695-698.
Kang, D. et al. (1998). Reciprocal Subtraction Differential RNA Display: An Efficient And Rapid Procedure For Isolating Differentially Expressed Gene Sequences. Proc Natl Acad Sci U S A 95, 13788-13793.
Su, Z. Z. et al. (1998). The Cancer Growth Suppressor Gene Mda-7 Selectively Induces Apoptosis In Human Breast Cancer Cells And Inhibits Tumor Inhibits Tumor Growth In Nude Mice. Proc Natl Acad Sci U S A 95, 14400-14405.
Jiang, H. et al. (1996). The Melanoma Differentiation Associated Gene Mda-7 Suppresses Cancer Cell Growth. Proc Natl Acad Sci U S A 93, 9160-9165.
Jiang, H. et al. (1995). Cell Cycle Gene Expression And E2F Transcription Factor Complexes In Human Melanoma Cells Induced To Terminally Differentiate. Oncogene 11, 1179-1189.
Jiang, H. et al. (1995) Subtraction Hybridization Identifies A Novel Melanoma Differentiation Associated Gene, mda-7, Modulated During Human Melanoma Differentiation, Growth and Progression. Oncogene;11(12):2477-2486.
Jiang H. et al. (1995) The Melanoma Differentiation-Associated Gene Mda-6, Which Encodes The Cyclin-Dependent Kinase Inhibitor p21, Is Differentially Expressed During Growth, Differentiation, And Progression In Human Melanoma Cells. Oncogene;10(9):1855-1864.
Fisher, P. B. Human MDA-7 (mda-7) mRNA, Complete Cds. GenBank Accession No. U16261. Deposited (1994).
Jiang, H., et al. (1994). A Molecular Definition Of Terminal Cell Differentiation In Human Melanoma Cells. Mol Cell Different 2, 221-239.
Su, Z. Z., et al. (1994). Induction Of Transformation Progression In Type 5 Adenovirus-Transformed Rat Embryo Cells By A Cloned Protein Kinase C Beta 1 Gene And Reversal Of Progression By 5-Azacytidine. Oncogene 9, 1123-1132.
Hara E, et al. (1993) DNA-DNA Subtractive cDNA Cloning Using Oligo(dT)30-Latex And PCR: Identification Of Cellular Genes Which Are Overexpressed In Senescent Human Diploid Fibroblasts. Anal Biochem; 214(1):58-64.
Jiang, H., et al. (1993). Regulation Of c-foc, c-jun And jun-B Gene Expression In Human Melanoma Cells Induced To Terminally Differentiate. Mol Cell Different 1, 197-214.
Jiang H, et al. (1993) Use Of A Sensitive And Efficient Subtraction Hybridization Protocol For The Identification Of Genes Differentially Regulated During The Induction Of Differentiation In Human Melanoma Cells. Mol Cell Different;1:285-299.
Reddy, PG, et al. (1993). Identification And Cloning Of Genes Involved In Progression Of Transformed Phenotype. In: Chromosome and Genetic Analysis, Methods in Molecular Genetics, vol. 1, K. W. Adolph, ed. (Orlando, FL, Academic Press Inc.), pp. 68-102.
Su, Z. Z., et al. (1993). Defining The Critical Gene Expression Changes Associated With Expression And Suppression Of The Tumorigenic And Metastatic Phenotype In Ha-ras-Transformed Cloned Rat Embryo Fibroblast Cells. Oncogene 8, 1211-1219.
Su, ZZ, et al. (1993). Genetic Analysis Of Carcinogen Enhancement Of Type 5 Adenovirus Transformation Of Cloned Fischer Rat Embryo Fibroblast Cells. Mol Carcinog 8, 155-166.
Su, ZZ, et al. (1993). Wild-Type Adenovirus Type 5 Transforming Genes Function As Transdominant Suppressors Of Oncogenesis In Mutant Adenovirus Type 5 Transformed Rat Embryo Fibroblast Cells. Cancer Res 53, 1929-1938.
Su, Z. Z. et al. (1992). Transfer Of A Dominant-Acting Tumor-Inducing Oncogene From Human Prostatic Carcinoma Cells To Cloned Rat Embryo Fibroblast Cells By DNA-Transfection. Anticancer Res;12(2):297-304.
Hara, E. et al. (1991). Subtractive cDNA Cloning Using oligo(dT)30-latex And PCR: Isolation Of cDNA Clones Specific To Undifferentiated Human Embryonal Carcinoma Cells. Nucleic Acids Res;19(25):7097-7104.
Herfort MR, et al. (1991). Simple And Efficient Subtractive Hybridization Screening. Biotechniques;11(5):598, 600, 602-604.
Lee S.W., et al. (1991).
Baker & Botts L.L.P.
Chen Shin-Lin
The Trustees of Columbia University in the City of New York
LandOfFree
Methods of treating various cancers using melanoma... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating various cancers using melanoma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating various cancers using melanoma... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3851433